In this Expert Interview from ASCO 2008, Dr. Robert Motzer discusses the evolving role of mTOR inhibition in the treatment of renal cell carcinoma, with a focus on the newest agent in the class. Medscape Hematology-Oncology
A combination of 4 novel urine biomarkers achieved a specificity and positive predictive value for prostate cancer that was more accurate than the PSA and the PCA3. Medscape Medical News
Radioactive microsphere therapy appears to prolong survival in patients with unresectable, chemorefractory metastatic disease of the liver, findings from a prospective, open-label phase II study indicate. Reuters Health Information
In older patients with diffuse large B-cell lymphoma, 6 cycles of CHOP-14 with added rituximab improved event-free and overall survival and was as effective as 8 cycles of the same regimen. Medscape Medical News
Children with this genetic variant, identified for the first time in a genome-wide association study, develop a particularly aggressive form of neuroblastoma. Medscape Medical News